Sources and licenses for the images in this editorial series. Photographs illustrate the topics; they do not depict the experiments discussed unless explicitly stated. Explanatory figures are original editorial artwork.
Why a Patent Filing Is Different from Medicine Approval
A historical engineering patent drawing
Drawing of device embodying Latham Loop patent.jpg · US Govt · Original source · Public domain · Unchanged Commons-supplied image, 1024 × 882 pixels.
Parallel questions in biomedical development
Original editorial figure · Original
Why a Cell Bank Matters When Making a Biologic Medicine
A laboratory Dewar vessel
Small laboratory Dewar.jpg · Karbohut · Original source · CC BY-SA 4.0 · Unchanged Commons-supplied image, 1920 × 2560 pixels.
Master and working cell-bank lineage
Original editorial figure · Original
Why Peptide Medicines Are Difficult to Deliver by Mouth
An example of a solid tablet format
FlattenedRoundPills.jpg · David Richfield · Original source · CC BY-SA 3.0 · Unchanged Commons-supplied image, 1920 × 1440 pixels.
Separate survival and absorption in oral peptide delivery
Original editorial figure · Original
How Extending a Peptide’s Half-Life Changes Its Design
Human serum albumin structural model
ChimeraX rendering of HSA (PDB 1AO6).png · 0fb1d8 · Original source · CC BY-SA 4.0 · Unchanged Commons-supplied image, 1920 × 1688 pixels.
Illustrative half-life curves
Original editorial figure · Original
Somatostatin and Octreotide: Why an Analogue Changes More Than Length
Chemical structure of octreotide
Octreotide.svg · Fvasconcellos · Original source · Public domain · Unchanged Commons-supplied image, 1920 × 1899 pixels.
Peptide analogue design beyond residue count
Original editorial figure · Original
